To validate the in vivo inhibitory effect of Let‐7b‐5p on HCC progression, an experimental mouse model was established by injecting HepG2 cells from the Ctrl, Ctrl‐OE, and Let‐7b‐5p‐OE groups into mice. This evidence concerns the gene CTRL and hepatocellular carcinoma.